Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Medicinal Chemistry
|
May 25, 2011
Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
Molecular Biology of the Cell
|
June 12, 2002
The cytoplasmic tail of invariant chain regulates endosome fusion and morphology
Tommy W Nordeng, Tone F Gregers, Thomas Lasker Kongsvik, et al.
Proteins
|
August 12, 2003
A left-handed alpha-helix containing both L- and D-amino acids: the solution structure of the antimicrobial lipodepsipeptide tolaasin
Fabrice Jourdan, Silvia Lazzaroni, Blanca López Méndez, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
Mathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
Journal of Medicinal Chemistry
|
March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
Chemmedchem
|
March 7, 2017
1,3,5-Trisubstituted Pyrazoles as Potent Negative Allosteric Modulators of the mGlu<sub>2/3</sub> Receptors
Michiel Van Gool, Sergio A Alonso De Diego, Oscar Delgado, et al.
Biochemistry
|
April 14, 2007
Purification and characterization of the FeII- and alpha-ketoglutarate-dependent xanthine hydroxylase from Aspergillus nidulans
Gabriela M Montero-Morán, Meng Li, Erika Rendòn-Huerta, et al.
Organic & Biomolecular Chemistry
|
October 31, 2008
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling
Fabrice Jourdan, Christian Bubert, Mathew P Leese, et al.
Chemical Communications (Cambridge, England)
|
April 14, 2010
Chimeric microtubule disruptors
Mathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Medicinal Chemistry
|
May 25, 2011
Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
Molecular Biology of the Cell
|
June 12, 2002
The cytoplasmic tail of invariant chain regulates endosome fusion and morphology
Tommy W Nordeng, Tone F Gregers, Thomas Lasker Kongsvik, et al.
Proteins
|
August 12, 2003
A left-handed alpha-helix containing both L- and D-amino acids: the solution structure of the antimicrobial lipodepsipeptide tolaasin
Fabrice Jourdan, Silvia Lazzaroni, Blanca López Méndez, et al.
ACS Medicinal Chemistry Letters
|
January 17, 2012
Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
Mathew P Leese, Fabrice Jourdan, Wolfgang Dohle, et al.
Journal of Medicinal Chemistry
|
March 16, 2010
Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate
Fabrice Jourdan, Mathew P Leese, Wolfgang Dohle, et al.
Chemmedchem
|
March 7, 2017
1,3,5-Trisubstituted Pyrazoles as Potent Negative Allosteric Modulators of the mGlu<sub>2/3</sub> Receptors
Michiel Van Gool, Sergio A Alonso De Diego, Oscar Delgado, et al.
Biochemistry
|
April 14, 2007
Purification and characterization of the FeII- and alpha-ketoglutarate-dependent xanthine hydroxylase from Aspergillus nidulans
Gabriela M Montero-Morán, Meng Li, Erika Rendòn-Huerta, et al.
Organic & Biomolecular Chemistry
|
October 31, 2008
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling
Fabrice Jourdan, Christian Bubert, Mathew P Leese, et al.
Chemical Communications (Cambridge, England)
|
April 14, 2010
Chimeric microtubule disruptors
Mathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Page
of 1